Wuxi Biologics (Cayman) (HK:2269) has released an update.
WuXi Biologics (Cayman) Inc. successfully passed all proposed resolutions during their Annual General Meeting on June 19, 2024, with overwhelming shareholder support. Key approvals included the re-election of directors, the authorization of director remuneration, re-appointment of auditors, share issuance, and share repurchase mandates. Additionally, the adoption of the amended company articles was ratified with virtually unanimous consent.
For further insights into HK:2269 stock, check out TipRanks’ Stock Analysis page.
